Citi lowered its price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $20.00 (from $24.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Syndax Pharmaceuticals (SNDX) PT Lowered to $22 at Nomura/Instinet on Mixed 2Q ResultsAugust 11, 2017 8:54 AM Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 13c, Beats on Revenues; Offers FY17 OpEx GuidanceAugust 10, 2017 4:15 PM Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business UpdateAugust 10, 2017 4:05 PM